Faculty Publications
As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of Touro University, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to touro.scholar@touro.edu.
Total number of publications: 7,082
Enter a faculty name:
or browse faculty by school:
Administrative Offices
Graduate Schools
Health Sciences
Lander Colleges
Law Center
New York School of Career and Applied Studies (NYSCAS)
Touro University System
New York Medical College (NYMC)
Touro University California
Touro University Nevada
Rumore, M. M., & Vaidean, G. D. (2012). Development of a risk assessment tool for falls prevention in hospital inpatients based on the Medication Appropriateness Index (MAI) and Modified Beer’s Criteria. Innovations in Pharmacy, 3(1) [Article 73]. This material can be found here.
Rumore, M. M., & Vogenberg, F. R. (2016). Biosimilars: Still not quite ready for prime time. P & T, 41(6), 366, 368-375. This material can be found here.
Rumore, M. M., & Vogenberg, F. R. (2017). The HEAT initiative is gaining momentum. P & T, 42(5), 330-335. This material can be found here.
Rumore, M. M., Assefa, H., Basu, P., Kumar, P., & Patel, Y. (2015). Analysis of MedWatch alerts 2009-2014. Journal of the American Pharmacists Association, 55(2), e233-e234. doi:10.1331/JAPhA.2015.15515
Rumore, M. M., Choy, M., & Cohen, K. (2015). Medication repurposing in pediatric patients: Teaching old drugs new tricks. Journal of the American Pharmacists Association, 55(2), e240. doi:10.1331/JAPhA.2015.15515
Rumore, M. M., Cobb, E., Sullivan, M., & Wittman, D. (2016). Biosimilars: Opportunities and challenges for nurse practitioners. Journal for Nurse Practitioners, 12(3), 181-191. doi:10.1016/j.nurpra.2015.08.027
Rumore, M. M., Su, S., & Pellinen, J. (2016). Cyclophosphamide for suspected primary angiitis of the central nervous system in a patient with human immunodeficiency virus: A case report. International Journal of Case Reports and Images, 7(10), 644-652. This material can be found here.
Salbu, R. L., Farquharson, K., & Truc, S. (2015). Order-set changes aimed at improving appropriate prescribing in the elderly. The Consultant Pharmacist, 30(10), 581. doi:10.4140/TCP.n.2015.559
Salbu, R. L., Leipzig, R. M., Ko, F. C. (2016). Antihypertensives and cardiovascular medications. In A. R. Huang & L. Mallet (Eds.), Medication-related falls in older people: Causative factors and management strategies (pp. 147-160). Basel, Switzerland: Springer. doi:10.1007/978-3-319-32304-6_12
Salbu, R. L., Truc, S., Farquharson, K., & Leipzig, R. (2014). Order-set changes aimed at improving appropriate prescribing in the elderly: Preliminary results of a falls reduction program. The Consultant Pharmacist, 29(10), 678. doi:10.4140/TCP.n.2014.666
Samide, J., & Rumore, M. M. (2014). Intravenous acetaminophen usage in pediatric patients. Journal of the American Pharmacists Association, 54(2), e197. doi:10.1331/JAPhA.2014.14511
Samih, Y., Shyh, G., & Cohen, H. (2015). Assessment of body temperature range and variation in elderly populations in a long-term care facility. Journal of Pharmacy Practice, 28(3), 309. doi:10.1177/0897190015583953
Sasson, E., James, M., Wubshet, B., Todorov, D., & Cohen, H. (2017). Implementing psychopharmacology rounds in a nursing facility to improve antipsychotic usage. Consultant Pharmacist, 32(6), 352-359. This material can be found here.
Sasson, E., Peyko, V., Cohen, H., & Lois, W. (2015). Comparison of anaerobic antimicrobial therapy: Single vs double coverage. Journal of Pharmacy Practice, 28(3), 309. doi:10.1177/0897190015583953
Saxena, J., Basu, P., Jaligam, V., & Chandra, S. (2013). Phospate solubilization by a few fungal strains belonging to the genera Aspergillus and Penicillium. African Journal of Microbiology Research, 7(41), 4862-4869. This material can be found here.
Scandinaro, A., Nguyen, L., & Matsumoto, R. R. (2015). Modified dextromethorphan displays antidepressant-like effects in the forced swim test [Supplemental material]. FASEB Journal, 29(1), 931.1. This material can be found here.
Scheinberg, N., Salbu, R. L., Goswami, G., & Cohen, K. R.(2016). Treatment of diabetic autonomic neuropathy in older adults with diabetes mellitus. Consultant Pharmacist, 31(11), 633-645. doi:10.4140/TCP.n.2016.633
Schoenhaus, R. (2013). 2013 Prescott lecture: Embracing our roles as medication navigators. Journal of the American Pharmacists Association, 53(4), 362-364. doi:10.1331/JAPhA.2013.13522
Schott, H., Kwan, L. C., & Feldman, S. (1982, September). The role of surfactants in the release of very slightly soluble drugs from tablets. Journal of Pharmaceutical Sciences, 71(9), 1038-1045.
Senhaji-Tomza, B., Soliman, S. R., & Basu, P. (2015). Improving a curriculum through incremental changes based on programmatic assessment results. American Journal of Pharmaceutical Education, 79(5) [Article S4]. doi:10.5688/ajpe795S4
Shah, B. M., Kemp, R., & Clearfield, M. B. (2009) Using statins to treat healthy patients – are we there yet? Expert Review of Pharmacoeconomics and Outcomes Research, 9(2), 103-105. doi: 10.1586/erp.09.5 This material can be found here.
Shah-Manek, B. M., Galanto, J. S., Nguyen, H., & Ignoffo, R. J. (2017). Value frameworks for the patient-provider interaction: A comparison of the ASCO Value Framework versus NCCN Evidence Blocks in determining value in oncology. Journal of Managed & Specialty Care Pharmacy, 23(6-a), S13-S20. This material can be found here.
Shane, P. A., Vogt, E. (2013). The future of clinical pharmacy: Developing a holistic model. Pharmacy, 1(2), 228-236. This material can be found here.
Sharma, R., Park, T. E., & Moy, S. (2016). Ceftazidime-avibactam: A novel cephalosporin/β-lactamase inhibitor combination for the treatment of resistant gram-negative organisms. Clinical Therapeutics, 38(3), 431-444. doi:10.1016/j.clinthera.2016.01.018
Shaw, J., Reardon, G., Sandor, D., Rosen, R., & Ferguson, D. (2010). Validation of stopwatch measurements of erection duration against responses to the sexual encounter profile and international index of erectile function in patients treated with a phosphodiesterase type 5 inhibitor. The Journal of Sexual Medicine, 7(3), 1147-1159. This material can be found here.
